Articles related to OBESITY/WEIGHT MANAGEMENT

Orforglipron is a novel once-daily oral GLP-1 receptor agonist that has been shown to be effective in reducing weight in adults with obesity or overweight. Further studies are needed to establish whether the health benefits seen with injectable GLP-1 receptor agonists are shared by orforglipron.

The study offers interesting insights into methods for controlling weight by examining the effects of time-restricted eating and calorie restriction. Physicians who are curious about the most recent weight loss techniques and their varying efficacy levels should read this study.

Explore the benefits of time-restricted eating, a diet pattern that suggests fewer, regular meals and fasting periods could improve insulin resistance, brain health, and glycemic control, potentially reducing the risk of developing type 2 diabetes and obesity.

Dive into this fascinating clinical case of a 70-year-old patient with persistent diarrhea and weight loss, and help decipher the most appropriate management strategy in light of his unique clinical picture.

Explore the fascinating field of obesity management, where pharmacological treatments are combined with lifestyle modifications, to find out how doctors are reversing the trend in the fight against this epidemic on a global scale.

The World Health Organization advises against nonsugar sweeteners for weight control, citing potential long-term risks such as type 2 diabetes and cardiovascular diseases. Instead, reducing free sugars and opting for natural sweetness sources is recommended to enhance dietary quality.